What is NeuroEM Therapeutics worth?
$17.0Mlast known valuation
NeuroEM Therapeutics last raised $1.9M in its Seed Round (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for NeuroEM Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Seed Round | $1.9M | ▮ | ▮ |
| May 2024 | Seed Round | $360K | ▮ | ▮ |
How NeuroEM Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NeuroEM Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is NeuroEM Therapeutics worth?
- NeuroEM Therapeutics's last known valuation is $17.0M.
- How much has NeuroEM Therapeutics raised?
- NeuroEM Therapeutics has raised $6.2M in total funding across 2 recorded rounds.
- When did NeuroEM Therapeutics last raise?
- NeuroEM Therapeutics last raised in Apr 2025 (Seed Round), raising $1.9M.